Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT05061862
Active, not recruiting Observational

Cardiac Implantable Electronic Device (CIED) Research Study

NCT05061862 · tracked via the Priya Life Science USA tracker
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Observational
Started
2022-03-06
Last updated
2025-12-10

Condition(s) studied

Arrhythmias, CardiacBradycardiaTachycardia

Investigational drug(s) / intervention(s)

cardiac implantable electronic devices (CIEDs)

cardiac implantable electronic devices (CIEDs): Subjects will be implanted with various cardiac implantable electronic devices and followed according to their standard of care. Medical imaging will be collected at various stages of the implant procedure and/or non-invasive diagnostic collection at follow-up visits, as applicable.

Study summary

The study is designed to collect data on Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details, and/or patient characteristics to support development of future CIED products and procedures.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Subject is at least 18 years of age. 2. Subject is willing and able to provide written informed consent. 3. Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements Exclusion Criteria: 1. Subject is unwilling or unable to comply with study procedures as defined in the protocol. 2. Subject with a medical condition that precludes the patient from participation in the opinion of the investigator. 3. Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.

Primary outcome measure(s)

  • Product Development — 3 years
    Characterize Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details and/or patient characteristics to support development of future CIED products and procedures.

Trial sites (9)

FacilityCityRegionStatus
The Cardiac & Vascular Institute Gainesville Florida
Georgia Arrhythmia Consultants Macon Georgia
Oregon Health & Science University Hospital Portland Oregon
Lancaster General Hospital Lancaster Pennsylvania
Allegheny General Hospital Pittsburgh Pennsylvania
University of Virginia Medical Center Charlottesville Virginia
Inova Fairfax Hospital Falls Church Virginia
Sentara Norfolk General Hospital Norfolk Virginia
UZ Leuven - Campus Gasthuisberg Leuven Belgium

More Medtronic Cardiac Rhythm and Heart Failure trials in the USA

Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study) Active, not recruiting
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study Active, not recruiting
ELEVATE-HFpEF Clinical Study Recruiting
Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing Recruiting
Destination Therapy Post Approval Study Active, not recruiting

Other trials for the same condition

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System Recruiting
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring Active, not recruiting
Aveir DR Real-World Evidence Post-Approval Study Recruiting
Enlighten Study: The EV-ICD Post Approval Registry Active, not recruiting
Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05061862 on ClinicalTrials.gov ↗ ← All trials in the USA